Skip to content

Clinical trials

Completed Phase 3 Immunoglobulin Light-chain Amyloidosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunoglobulin Light-chain Amyloidosis Phase: Phase 3 Status: Completed Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20031
20052
20061
20072
20082
20101
20111
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology2
Jonsson Comprehensive Cancer Center2
Mayo Clinic2
Memorial Sloan Kettering Cancer Center2
Case Comprehensive Cancer Center1
European Myeloma Network B.V.1
European Organisation for Research and Treatment of Cancer - EORTC1
INSYS Therapeutics Inc1
Lantheus Germany GmbH1
NCIC Clinical Trials Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunoglobulin Light-chain Amyloidosis19
Multiple Myeloma14
Hodgkin Disease12
Immunoblastic Lymphadenopathy12
Leukemia, Lymphocytic, Chronic, B-Cell12
Lymphoma, Follicular12
Lymphoma, Large B-Cell, Diffuse12
Lymphoma, Large-Cell, Anaplastic12
Lymphoma, Large-Cell, Immunoblastic12
Lymphoma, Mantle-Cell12

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.